Discussion Posts

Thread Subject Replies Last Post Community
Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial
   
0 8 days ago by Natasha Olson Nuclear Pharmacy
Radiopharmaceuticals CE (1 hr)
   
0 10 days ago by Natasha Olson Nuclear Pharmacy
Join the Pharmacist Community Gathering - Nuclear Pharmacy Focus
   
0 19 days ago by Natasha Olson Nuclear Pharmacy
SHINE's Janesville facility has received a $263 million DOE conditional commitment
   
0 04-10-2026 by Natasha Olson Nuclear Pharmacy
Showing 1 to 4 of 4 threads (4 total posts)